Differential expression, function and response to inflammatory stimuli of 11β-hydroxysteroid dehydrogenase type 1 in human fibroblasts:: a mechanism for tissue-specific regulation of inflammation

被引:76
|
作者
Hardy, Rowan S.
Filer, Andrew
Cooper, Mark S.
Parsonage, Greg
Raza, Karim
Hardie, Debbie L.
Rabbitt, Elizabeth H.
Stewart, Paul M.
Buckley, Christopher D.
Hewison, Martin [1 ]
机构
[1] Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA
[2] Univ Birmingham, Sch Med, Div Med Sci, Inst Biomed Res, Birmingham, W Midlands, England
[3] Univ Birmingham, Sch Med, Div Immun & Infect, Inst Biomed Res, Birmingham, W Midlands, England
基金
英国医学研究理事会;
关键词
D O I
10.1186/ar1993
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Stromal cells such as fibroblasts play an important role in defining tissue-specific responses during the resolution of inflammation. We hypothesized that this involves tissue-specific regulation of glucocorticoids, mediated via differential regulation of the enzyme 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1). Expression, activity and function of 11 beta-HSD1 was assessed in matched fibroblasts derived from various tissues (synovium, bone marrow and skin) obtained from patients with rheumatoid arthritis or osteoarthritis. 11 beta-HSD1 was expressed in fibroblasts from all tissues but mRNA levels and enzyme activity were higher in synovial fibroblasts (2-fold and 13-fold higher mRNA levels in dermal and synovial fibroblasts, respectively, relative to bone marrow). Expression and activity of the enzyme increased in all fibroblasts following treatment with tumour necrosis factor-alpha or IL-1 beta (bone marrow: 8-fold and 37-fold, respectively, compared to vehicle; dermal fibroblasts: 4-fold and 14-fold; synovial fibroblasts: 7-fold and 31-fold; all P < 0.01 compared with vehicle). Treatment with IL-4 or interferon-gamma was without effect, and there was no difference in 11 beta-HSD1 expression between fibroblasts (from any site) obtained from patients with rheumatoid arthritis or osteoarthritis. In the presence of 100 nmol/l cortisone, IL-6 production - a characteristic feature of synovial derived fibroblasts - was significantly reduced in synovial but not dermal or bone marrow fibroblasts. This was prevented by co-treatment with an 11 beta-HSD inhibitor, emphasizing the potential for autocrine activation of glucocorticoids in synovial fibroblasts. These data indicate that differences in fibroblast-derived glucocorticoid production (via the enzyme 11 beta-HSD1) between cells from distinct anatomical locations may play a key role in the predeliction of certain tissues to develop persistent inflammation.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Differential expression, function and response to inflammatory stimuli of 11β-hydroxysteroid dehydrogenase type 1 in human fibroblasts: a mechanism for tissue-specific regulation of inflammation
    Rowan S Hardy
    Andrew Filer
    Mark S Cooper
    Greg Parsonage
    Karim Raza
    Debbie L Hardie
    Elizabeth H Rabbitt
    Paul M Stewart
    Christopher D Buckley
    Martin Hewison
    [J]. Arthritis Research & Therapy, 8
  • [2] Autocrine regulation of glucocorticoids by 11 beta-hydroxysteroid dehydrogenase type 1: A mechanism for tissue-specific regulation of inflammation
    Hardy, RS
    Filer, A
    Parsonage, G
    Buckley, CD
    Stewart, PM
    Cooper, MS
    Hewison, M
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (07) : 1298 - 1298
  • [3] Regulation of expression of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue:: Tissue-specific induction by cytokines
    Tomlinson, JW
    Moore, J
    Cooper, MS
    Bujalska, I
    Shahmanesh, M
    Burt, C
    Strain, A
    Hewison, M
    Stewart, PM
    [J]. ENDOCRINOLOGY, 2001, 142 (05) : 1982 - 1989
  • [4] 11β-hydroxysteroid dehydrogenase type 1:: A tissue-specific regulator of glucocorticoid response
    Tomlinson, JW
    Walker, EA
    Bujalska, IJ
    Draper, N
    Lavery, GG
    Cooper, MS
    Hewison, M
    Stewart, PM
    [J]. ENDOCRINE REVIEWS, 2004, 25 (05) : 831 - 866
  • [5] The role and regulation of 11β-hydroxysteroid dehydrogenase type 1 in the inflammatory response
    Chapman, Karen E.
    Coutinho, Agnes E.
    Gray, Mohini
    Gilmour, James S.
    Savill, John S.
    Seckl, Jonathan R.
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 301 (1-2) : 123 - 131
  • [6] Tissue-specific dysregulation of 11β-hydroxysteroid dehydrogenase type 1 and pathogenesis of the metabolic syndrome
    Putignano, P
    Giraldi, FP
    Cavagnini, F
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2004, 27 (10) : 969 - 974
  • [7] Minireview:: 11β-hydroxysteroid dehydrogenase type 1 -: A tissue-specific amplifier of glucocorticoid action
    Seckl, JR
    Walker, BR
    [J]. ENDOCRINOLOGY, 2001, 142 (04) : 1371 - 1376
  • [8] Tissue-specific dysregulation of 11β-hydroxysteroid dehydrogenase type 1 and pathogenesis of the metabolic syndrome
    P. Putignano
    F. Pecori Giraldi
    F. Cavagnini
    [J]. Journal of Endocrinological Investigation, 2004, 27 : 969 - 974
  • [9] Differential induction of fibroblast 11ß-HSD1:: A mechanism for tissue-specific regulation of inflammation
    Hardy, R. S.
    Cooper, M. S.
    Filer, A.
    Parsonage, G.
    Raza, K.
    Buckley, C. D.
    Hewison, M.
    [J]. RHEUMATOLOGY, 2006, 45 : I37 - I37
  • [10] Tissue-Specific Increases in 11β-Hydroxysteroid Dehydrogenase Type 1 in Normal Weight Postmenopausal Women
    Andersson, Therese
    Simonyte, Kotryna
    Andrew, Ruth
    Strand, Magnus
    Buren, Jonas
    Walker, Brian R.
    Mattsson, Cecilia
    Olsson, Tommy
    [J]. PLOS ONE, 2009, 4 (12):